Global Single-cell Technologies Market Research Report 2024

Publication ID:

PB511246171

Publication Date:

November 8, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Single-cell technologies refer to a series of technical means for analyzing and studying single cells. Single-cell technology is a high-throughput, high-resolution analysis method that allows researchers to obtain genetic information and molecular characteristics at the single cell level. These technologies include but are not limited to single-cell RNA sequencing and single-cell genome sequencing.
The global Single-cell Technologies market was valued at US$ 3584 million in 2023 and is anticipated to reach US$ 10160 million by 2030, witnessing a CAGR of 15.9% during the forecast period 2024-2030.
North American market for Single-cell Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-cell Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single-cell Technologies in Research Applications is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single-cell Technologies include Agilent, BD Biosciences, Bio-Rad, Danaher Life Sciences, 10X Genomics, Merck KGaA, Illumina, Promega Corporation, QIAGEN, Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single-cell Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-cell Technologies.
The Single-cell Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-cell Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-cell Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent
BD Biosciences
Bio-Rad
Danaher Life Sciences
10X Genomics
Merck KGaA
Illumina
Promega Corporation
QIAGEN
Thermo Fisher Scientific
Segment by Type
Human Cells
Animal Cells
Microbial Cells
Segment by Application
Research Applications
Medical Applications
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-cell Technologies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single-cell Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Human Cells
1.2.3 Animal Cells
1.2.4 Microbial Cells
1.3 Market by Application
1.3.1 Global Single-cell Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Applications
1.3.3 Medical Applications
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-cell Technologies Market Perspective (2019-2030)
2.2 Global Single-cell Technologies Growth Trends by Region
2.2.1 Global Single-cell Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single-cell Technologies Historic Market Size by Region (2019-2024)
2.2.3 Single-cell Technologies Forecasted Market Size by Region (2025-2030)
2.3 Single-cell Technologies Market Dynamics
2.3.1 Single-cell Technologies Industry Trends
2.3.2 Single-cell Technologies Market Drivers
2.3.3 Single-cell Technologies Market Challenges
2.3.4 Single-cell Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-cell Technologies Players by Revenue
3.1.1 Global Top Single-cell Technologies Players by Revenue (2019-2024)
3.1.2 Global Single-cell Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Single-cell Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single-cell Technologies Revenue
3.4 Global Single-cell Technologies Market Concentration Ratio
3.4.1 Global Single-cell Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-cell Technologies Revenue in 2023
3.5 Global Key Players of Single-cell Technologies Head office and Area Served
3.6 Global Key Players of Single-cell Technologies, Product and Application
3.7 Global Key Players of Single-cell Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-cell Technologies Breakdown Data by Type
4.1 Global Single-cell Technologies Historic Market Size by Type (2019-2024)
4.2 Global Single-cell Technologies Forecasted Market Size by Type (2025-2030)
5 Single-cell Technologies Breakdown Data by Application
5.1 Global Single-cell Technologies Historic Market Size by Application (2019-2024)
5.2 Global Single-cell Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single-cell Technologies Market Size (2019-2030)
6.2 North America Single-cell Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single-cell Technologies Market Size by Country (2019-2024)
6.4 North America Single-cell Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-cell Technologies Market Size (2019-2030)
7.2 Europe Single-cell Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single-cell Technologies Market Size by Country (2019-2024)
7.4 Europe Single-cell Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-cell Technologies Market Size (2019-2030)
8.2 Asia-Pacific Single-cell Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single-cell Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Single-cell Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-cell Technologies Market Size (2019-2030)
9.2 Latin America Single-cell Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single-cell Technologies Market Size by Country (2019-2024)
9.4 Latin America Single-cell Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-cell Technologies Market Size (2019-2030)
10.2 Middle East & Africa Single-cell Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single-cell Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Single-cell Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Single-cell Technologies Introduction
11.1.4 Agilent Revenue in Single-cell Technologies Business (2019-2024)
11.1.5 Agilent Recent Development
11.2 BD Biosciences
11.2.1 BD Biosciences Company Details
11.2.2 BD Biosciences Business Overview
11.2.3 BD Biosciences Single-cell Technologies Introduction
11.2.4 BD Biosciences Revenue in Single-cell Technologies Business (2019-2024)
11.2.5 BD Biosciences Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Single-cell Technologies Introduction
11.3.4 Bio-Rad Revenue in Single-cell Technologies Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Danaher Life Sciences
11.4.1 Danaher Life Sciences Company Details
11.4.2 Danaher Life Sciences Business Overview
11.4.3 Danaher Life Sciences Single-cell Technologies Introduction
11.4.4 Danaher Life Sciences Revenue in Single-cell Technologies Business (2019-2024)
11.4.5 Danaher Life Sciences Recent Development
11.5 10X Genomics
11.5.1 10X Genomics Company Details
11.5.2 10X Genomics Business Overview
11.5.3 10X Genomics Single-cell Technologies Introduction
11.5.4 10X Genomics Revenue in Single-cell Technologies Business (2019-2024)
11.5.5 10X Genomics Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Single-cell Technologies Introduction
11.6.4 Merck KGaA Revenue in Single-cell Technologies Business (2019-2024)
11.6.5 Merck KGaA Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Single-cell Technologies Introduction
11.7.4 Illumina Revenue in Single-cell Technologies Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Promega Corporation
11.8.1 Promega Corporation Company Details
11.8.2 Promega Corporation Business Overview
11.8.3 Promega Corporation Single-cell Technologies Introduction
11.8.4 Promega Corporation Revenue in Single-cell Technologies Business (2019-2024)
11.8.5 Promega Corporation Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Details
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Single-cell Technologies Introduction
11.9.4 QIAGEN Revenue in Single-cell Technologies Business (2019-2024)
11.9.5 QIAGEN Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Single-cell Technologies Introduction
11.10.4 Thermo Fisher Scientific Revenue in Single-cell Technologies Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Agilent
BD Biosciences
Bio-Rad
Danaher Life Sciences
10X Genomics
Merck KGaA
Illumina
Promega Corporation
QIAGEN
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂